4-Aminosalicylic acid
(Synonyms: 4-氨基水杨酸) 目录号 : GC60511A PABA antimetabolite with antibacterial activity
Cas No.:65-49-6
Sample solution is provided at 25 µL, 10mM.
4-Aminosalicylic acid is an antimetabolite of p-aminobenzoic acid that has antibacterial activity.1,2 It is active against streptomycin-sensitive and -resistant strains of M. tuberculosis (MICs = 0.78 and 0.39 ?g/ml, respectively), an effect that can be reversed by PABA.1 4-Aminosalicylic acid is an alternative substrate for mycobacterial dihydropteroate synthase (FolP1) and misincorporation into the folate pathway leads to accumulation of several folate-dependent metabolites including serine, homocysteine, dUMP, and AICAR, markers of folate pathway inhibition, in a concentration-dependent manner.2 It reverses manganese-induced increases in rat hippocampal levels of NOD-like receptor protein 3 (NLRP3), cleaved caspase-1, and phosphorylated p65, markers of NLRP3 inflammasome-dependent pyroptosis, when administered at a dose of 300 mg/kg.3 4-Aminosalycilic acid is also a building block that has been used in the synthesis of luminescent lanthanide complexes.4 Formulations containing 4-aminosalicylic acid have been used in the treatment of tuberculosis.
1.Youmans, G.P., Raleigh, G.W., and Youmans, A.S.The tuberculostatic action of para-aminosalicylic acidJ. Bacteriol.54(4)409-416(1947) 2.Chakraborty, S., Gruber, T., Barry, C.E., III, et al.Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosisScience339(6115)88-91(2013) 3.Peng, D., Li, J., Deng, Y., et al.Sodium para-aminosalicylic acid inhibits manganese-induced NLRP3 inflammasome-dependent pyroptosis by inhibiting NF-κB pathway activation and oxidative stressJ. Neuroinflammation17(1)343(2020) 4.Terai, T., Ito, H., Kikuchi, K., et al.Salicylic-acid derivatives as antennae for ratiometric luminescent probes based on lanthanide complexesChemistry18(24)7377-7381(2012)
Cas No. | 65-49-6 | SDF | |
别名 | 4-氨基水杨酸 | ||
Canonical SMILES | O=C(O)C1=CC=C(N)C=C1O | ||
分子式 | C7H7NO3 | 分子量 | 153.14 |
溶解度 | DMF: 30 mg/ml,DMSO: 30 mg/ml,Ethanol: 30 mg/ml | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 6.53 mL | 32.6499 mL | 65.2997 mL |
5 mM | 1.306 mL | 6.53 mL | 13.0599 mL |
10 mM | 0.653 mL | 3.265 mL | 6.53 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >97.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet